Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
Avadel Pharmaceuticals (Nasdaq: AVDL) has announced its upcoming participation in the 24th Annual Needham Healthcare Conference. The company's management team will engage in a fireside chat scheduled for Tuesday, April 8 at 1:30 p.m. ET.
Investors and interested parties can access a live webcast of the presentation through Avadel's Investor Relations website at investors.avadel.com. The recorded session will remain available on the website for 90 days following the conference.
Avadel Pharmaceuticals (Nasdaq: AVDL) ha annunciato la sua prossima partecipazione alla 24ª Conferenza Annuale sulla Salute di Needham. Il team di gestione dell'azienda parteciperà a una chiacchierata informale programmata per martedì 8 aprile alle 13:30 ET.
Investitori e parti interessate possono accedere a una trasmissione in diretta della presentazione attraverso il sito web delle Relazioni con gli Investitori di Avadel all'indirizzo investors.avadel.com. La registrazione della sessione rimarrà disponibile sul sito per 90 giorni dopo la conferenza.
Avadel Pharmaceuticals (Nasdaq: AVDL) ha anunciado su próxima participación en la 24ª Conferencia Anual de Salud de Needham. El equipo de gestión de la empresa participará en una charla informal programada para el martes 8 de abril a la 1:30 p.m. ET.
Los inversores y partes interesadas pueden acceder a una transmisión en vivo de la presentación a través del sitio web de Relaciones con Inversores de Avadel en investors.avadel.com. La sesión grabada estará disponible en el sitio durante 90 días después de la conferencia.
Avadel Pharmaceuticals (Nasdaq: AVDL)은 제24회 니드햄 헬스케어 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사의 경영진은 4월 8일 화요일 오후 1시 30분 ET에 예정된 파이어사이드 채팅에 참여할 것입니다.
투자자 및 관심 있는 분들은 Avadel의 투자자 관계 웹사이트인 investors.avadel.com를 통해 발표의 라이브 웹캐스트에 접근할 수 있습니다. 녹화된 세션은 컨퍼런스 이후 90일 동안 웹사이트에서 이용 가능합니다.
Avadel Pharmaceuticals (Nasdaq: AVDL) a annoncé sa prochaine participation à la 24e Conférence Annuelle de Needham sur la Santé. L'équipe de direction de l'entreprise participera à une discussion informelle prévue pour mardi 8 avril à 13h30 ET.
Les investisseurs et les parties intéressées peuvent accéder à un webcast en direct de la présentation via le site web des Relations avec les Investisseurs d'Avadel à l'adresse investors.avadel.com. La session enregistrée restera disponible sur le site pendant 90 jours après la conférence.
Avadel Pharmaceuticals (Nasdaq: AVDL) hat seine bevorstehende Teilnahme an der 24. jährlichen Needham Healthcare-Konferenz angekündigt. Das Management-Team des Unternehmens wird an einem Fireside-Chat teilnehmen, der für Dienstag, den 8. April um 13:30 Uhr ET geplant ist.
Investoren und Interessierte können über die Investor Relations-Website von Avadel unter investors.avadel.com auf einen Live-Stream der Präsentation zugreifen. Die aufgezeichnete Sitzung bleibt 90 Tage nach der Konferenz auf der Website verfügbar.
- None.
- None.
DUBLIN, April 01, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the 24th Annual Needham Healthcare Conference on Tuesday, April 8 at 1:30 p.m. ET.
A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.
About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or EDS in patients 7 years of age and older with narcolepsy. For more information, please visit www.avadel.com.
Investor Contact:
Austin Murtagh
Precision AQ
Austin.Murtagh@precisionAQ.com
(212) 698-8696
Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162
FAQ
When is Avadel Pharmaceuticals (AVDL) presenting at the Needham Healthcare Conference?
How can investors watch Avadel's (AVDL) Needham Conference presentation?
How long will Avadel's (AVDL) Needham Conference presentation be available for replay?
What type of presentation will AVDL give at the Needham Healthcare Conference?
